Glenmark Pharmaceuticals Sees Surge in Active Call Options Amid High Trading Volume

Glenmark Pharmaceuticals Ltd. has emerged as one of the most active stocks today, particularly in the options market. The company, operating within the Pharmaceuticals & Biotechnology sector, has seen significant trading activity in call options set to expire on July 31, 2025. Notably, the call option with a strike price of Rs 2200 recorded 4,308 contracts traded, generating a turnover of Rs 1,416.63 lakhs, while maintaining an open interest of 2,281 contracts.
Additionally, the Rs 2260 strike price option saw 5,690 contracts traded with a turnover of Rs 1,306.71 lakhs and an open interest of 1,060. The most active option was the Rs 2300 strike price, which had 7,583 contracts traded, resulting in a turnover of Rs 1,287.31 lakhs and an open interest of 2,092.

In terms of stock performance, Glenmark is currently trading at Rs 2,195.4, just 3.57% away from its 52-week high of Rs 2,284.8. Despite this, the stock has underperformed its sector by 0.29% today and has shown a slight decline of 0.22% in its one-day return. The stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally positive trend. However, investor participation has decreased, with delivery volume dropping by 63.58% compared to the 5-day average.

Overall, Glenmark Pharmaceuticals continues to attract attention in the market, reflecting a blend of active trading in options and notable performance metrics.